Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Highlights

Highlights March 5, 2014 Volume 311, Number 9 In This Issue of JAMA Pages 875-978 Research Opinion Viewpoint Warfarin and Outcomes Among Patients With CKD and AF 919 903 Legal and Ethical Responsibilities In analysis of registry data from 24 317 patients admitted to hospital with myocardial Following Brain Death: The McMath infarction and preexisting or new atrial fibrillation (AF), Carrero and colleagues investigated and Muñoz Cases outcomes associated with warfarin treatment in relation to kidney function. The authors LO Gostin report that warfarin treatment was associated with a lower 1-year risk of a composite 905 Evaluating the Risks of Electric outcome of death, myocardial infarction, and ischemic stroke without a higher risk of Uterine Morcellation KA Kho and CH Nezhat bleeding—unrelated to the severity of concurrent chronic kidney disease (CKD). In an Editorial, Winkelmayer and Turakhia discuss implications of the findings for patient care. 907 What is the Public’s Right to Access Medical Discoveries Based on Federally Related Editorial 913 Funded Reseach? Author Audio Interview jama.com CL Treasure and Coauthors 909 Reward-Based Incentives for Casinos and Risk of Childhood Overweight and Obesity 929 Smoking Cessation: How a Carrot Childhood overweight and obesity have been inversely associated with economic Became http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Highlights

JAMA , Volume 311 (9) – Mar 5, 2014
Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/highlights-VM9leoQvN2

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2013.279360
Publisher site
See Article on Publisher Site

Abstract

March 5, 2014 Volume 311, Number 9 In This Issue of JAMA Pages 875-978 Research Opinion Viewpoint Warfarin and Outcomes Among Patients With CKD and AF 919 903 Legal and Ethical Responsibilities In analysis of registry data from 24 317 patients admitted to hospital with myocardial Following Brain Death: The McMath infarction and preexisting or new atrial fibrillation (AF), Carrero and colleagues investigated and Muñoz Cases outcomes associated with warfarin treatment in relation to kidney function. The authors LO Gostin report that warfarin treatment was associated with a lower 1-year risk of a composite 905 Evaluating the Risks of Electric outcome of death, myocardial infarction, and ischemic stroke without a higher risk of Uterine Morcellation KA Kho and CH Nezhat bleeding—unrelated to the severity of concurrent chronic kidney disease (CKD). In an Editorial, Winkelmayer and Turakhia discuss implications of the findings for patient care. 907 What is the Public’s Right to Access Medical Discoveries Based on Federally Related Editorial 913 Funded Reseach? Author Audio Interview jama.com CL Treasure and Coauthors 909 Reward-Based Incentives for Casinos and Risk of Childhood Overweight and Obesity 929 Smoking Cessation: How a Carrot Childhood overweight and obesity have been inversely associated with economic Became

Journal

JAMA – American Medical Association

Published: Mar 5, 2014

There are no references for this article.